Killick Kirsty, Macaden Leah, Smith Annetta, Kroll Thilo, Stoddart Kathleen, Watson Margaret C
Edinburgh Napier University, Sighthill Campus, Edinburgh, UK.
Department of Nursing, Centre for Health Science, University of the Highlands and Islands, Inverness, UK.
Int J Pharm Pract. 2018 Oct;26(5):380-386. doi: 10.1111/ijpp.12456. Epub 2018 Jun 19.
This scoping review collated evidence of the pharmaceutical care needs of people with sensory loss (SL).
Electronic databases were searched with no limit on year of publication: Medline (1946); Embase; Cinahl (1979); and Web of Science (1985). Search terms included the following: pharmacy; sight/hearing/dual impairment. Studies were included if they involved people with SL requiring pharmaceutical care and/or pharmacists/pharmacy support staff providing pharmaceutical care for people with SL. All study designs were eligible. This was a scoping review, and as such, the quality of studies was not formally evaluated.
Eleven studies were included. People with SL had lower levels of medication knowledge than their peers without SL. People with SL were identified as being at higher risk of iatrogenic harm than people without SL. Communication was a barrier to the provision of pharmaceutical care for people with hearing loss, with pharmacists relying on the provision of written information. The prevalence of SL increases with age, yet only two studies included older people. No studies involved family or carers of people with SL, people with dual loss or people with SL receiving polypharmacy.
There is a paucity of data regarding the pharmaceutical care needs of people with SL. Unmet pharmaceutical care needs put people with SL at increased risk of harm from their medicines. A detailed understanding of the needs of people with SL is required which will inform future delivery of pharmaceutical care for this vulnerable population.
本范围综述整理了感官丧失(SL)患者药物治疗需求的证据。
检索电子数据库,对发表年份无限制:Medline(1946年起);Embase;Cinahl(1979年起);以及Web of Science(1985年起)。检索词包括以下内容:药学;视力/听力/双重损伤。如果研究涉及需要药物治疗的SL患者和/或为SL患者提供药物治疗的药剂师/药房支持人员,则纳入该研究。所有研究设计均符合要求。这是一项范围综述,因此未对研究质量进行正式评估。
纳入了11项研究。与没有SL的同龄人相比,SL患者的用药知识水平较低。与没有SL的人相比,SL患者被确定为发生医源性伤害的风险更高。沟通是为听力损失患者提供药物治疗的障碍,药剂师依赖提供书面信息。SL的患病率随年龄增长而增加,但只有两项研究纳入了老年人。没有研究涉及SL患者的家人或照顾者、双重丧失患者或接受多种药物治疗的SL患者。
关于SL患者药物治疗需求的数据匮乏。未满足的药物治疗需求使SL患者因药物而受到伤害的风险增加。需要详细了解SL患者的需求,这将为今后为这一弱势群体提供药物治疗提供依据。